Missing flash drive cause of Kaiser breach

Laura Pedulli | | Health Exec | Cybersecurity

The protected health information of more than 49,000 patients at Kaiser’s Anaheim Medical Center is at risk after a computer flash drive went missing, according to the Los Angeles Times.

The flash drive was reported missing on Sept. 25 from inside the hospital’s nuclear medicine department. Information at risk include patient names, dates of birth, medical record numbers and the types and amounts of specific medications. No financial information, including Social Security numbers, were compromised.

The missing data weren’t encrypted nor password protected, thus Kaiser is encouraging patients to monitor their medical records for fraudulent activities, according to the article.

"Kaiser Permanente takes the protection of our members' personal and health information seriously, and we apologize for this occurrence," Kaiser spokesperson Peggy Hinz said in statement.

Laura Pedulli

Related Content

FBI seeking extradition of Israeli prisoner accused of $500M in ransomware attacks
Data breach at chain of clinics impacts 450K patients
Nebraska becomes first state to sue Change Healthcare over data breach
Christmas ransomware exposed over 300K patient records to dark web
Cryo-frozen tissue manufacturer suffers cyberattack
First surgical device of its kind granted key FDA exemption

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.